Dual-Time-Point 18F-FDG PET/CT in Infective Endocarditis: Impact of Delayed Imaging in the Definitive Diagnosis of Endocarditis
- PMID: 38672215
- PMCID: PMC11048229
- DOI: 10.3390/biomedicines12040861
Dual-Time-Point 18F-FDG PET/CT in Infective Endocarditis: Impact of Delayed Imaging in the Definitive Diagnosis of Endocarditis
Abstract
Infective endocarditis (IE) is a major public health condition due to the associated high morbidity and mortality. Our objective was to evaluate the utility of dual-time 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) imaging in the diagnosis of active IE in patients with suspected native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE). For this purpose, a retrospective study was carried out, including patients suspicious of NVE or PVE who underwent a dual-time-point 18F-FDG PET/CT. A final diagnosis was established by the Endocarditis Team after patient follow-up using all the available findings. Sixty-nine patients were assessed. A final diagnosis of NVE was established in 3 patients of the 34 by 18F-FDG PET/CT and in the case of PVE was established in 20 patients of the 35. A statistically significant association was found when evaluating the association between PET diagnosis at early acquisition and final diagnosis of IE (χ2 = 30.198, p < 0.001) and PET diagnosis at delayed acquisition for final diagnosis of IE (χ2 = 9.412, p = 0.002). Delayed PET/CT imaging determined the IE diagnosis in 16/58 of the studies. In conclusion, delayed 18F-FDG PET/CT imaging seems to be useful in improving the definitive diagnosis of IE.
Keywords: PET/CT; dual-time-point; infective endocarditis; native valve; prosthetic valve.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Institute for Health Metrics Evaluation GPllobal Burden of Disease Metrics. University of Washington, Seattle. [(accessed on 1 October 2021)]. Available online: https://vizhub.healthdata.org/gbd-compare/
-
- Momtazmanesh S., Saeedi Moghaddam S., Malakan Rad E., Azadnajafabad S., Ebrahimi N., Mohammadi E., Rouhifard M., Rezaei N., Masinaei M., Rezaei N., et al. Global, Regional, and National Burden and Quality of Care Index of Endocarditis: The Global Burden of Disease Study 1990–2019. Eur. J. Prev. Cardiol. 2022;29:1287–1297. doi: 10.1093/eurjpc/zwab211. - DOI - PubMed
-
- Heredia-Rodríguez M., Hernández A., Bustamante-Munguira J., Álvarez F.J., Eiros J.M., Castrodeza J., Tamayo E. Evolution of the Incidence, Mortality, and Cost of Infective Endocarditis in Spain Between 1997 and 2014. J. Gen. Intern. Med. 2018;33:1610–1613. doi: 10.1007/s11606-018-4514-7. - DOI - PMC - PubMed
-
- Jensen A.D., Bundgaard H., Butt J.H., Bruun N.E., Voldstedlund M., Torp-Pedersen C., Gislason G., Iversen K., Chamat S., Dahl A., et al. Temporal Changes in the Incidence of Infective Endocarditis in Denmark 1997–2017: A Nationwide Study. Int. J. Cardiol. 2021;326:145–152. doi: 10.1016/j.ijcard.2020.10.029. - DOI - PubMed
-
- Van Den Brink F.S., Swaans M.J., Hoogendijk M.G., Alipour A., Kelder J.C., Jaarsma W., Eefting F.D., Groenmeijer B., Kupper A.J.F., Ten Berg J.M. Increased Incidence of Infective Endocarditis after the 2009 European Society of Cardiology Guideline Update: A Nationwide Study in the Netherlands. Eur. Heart J. Qual. Care Clin. Outcomes. 2017;3:141–147. doi: 10.1093/ehjqcco/qcw039. - DOI - PubMed
LinkOut - more resources
Full Text Sources